← Leaderboards
Thais Motria Sielecki
Lignamed, Llc
$3,266,618
Attributed
$6,533,236
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2017–21$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,533,236 · 5
By mechanism
R42$2,964,295 · 1
R44$2,655,879 · 1
R41$913,062 · 3
Top collaborators
- Angela Haczku4 shared
- Jason D Christie2 shared
- Edward Cantu1 shared
- Melpo Christofidou-Solomidou1 shared
- Constantinos Koumenis1 shared
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsPathway InteractionsPennsylvaniaRegulationUniversitiesAntioxidantsInflammationEffectivenessNonhuman PrimateBaseAffectGenetic TranscriptionFree Radical ScavengingBloodOralInhibitor/AntagonistPropertyInhalationPreventCollaborationsLeadEvaluationLungChronic
Grant awards (9)
IND enabling development of LGM2605 as adjuvant treatment for asthma$964,295
R42 · FY2021 · AI · contact PI
Optimization of LGM2605 for use as a device in lung transplant$916,148
R44 · FY2021 · HL · contact PI
Targeting the Integrated Stress Response effector ATF4 for mitigation of treatment-induced fibrosis$335,671
R41 · FY2021 · CA · contact PI
Optimization of LGM2605 for use as a device in lung transplant$1,440,044
R44 · FY2020 · HL · contact PI
IND enabling development of LGM2605 as adjuvant treatment for asthma$1,000,000
R42 · FY2020 · AI · contact PI
IND enabling development of LGM2605 as adjuvant treatment for asthma$1,000,000
R42 · FY2019 · AI · contact PI
Optimization of LGM2605 for use as a device in lung transplant$299,687
R44 · FY2018 · HL · contact PI
Graft-protective properties of LGM2605 in Lung Transplantation$299,599
R41 · FY2018 · HL · contact PI
Effects of LGM2605 on a Primate Model of Asthma$277,792
R41 · FY2017 · AI · contact PI